跳到正文
原文
Endpoints News 生物医药· Ayisha Sharma·· 15 天前AI 评分33

Alethio 筹集 9000 万美元推进 Essential Thrombocythemia 抗体药物开发

Alethio clinches $90M to advance antibody for essential thrombocythemia

AI 导读

Alethio Therapeutics 筹集 9000 万美元用于推进 Essential Thrombocythemia 抗体药物开发。公司于一年前从隐身模式中 emerge。

正文

About a year af­ter emerg­ing from stealth, Uni­ver­si­ty of Ox­ford spin­out Alethio Ther­a­peu­tics has col­lect­ed $90 mil­lion in a Se­ries A …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news